Management of Vitamin B12 Deficiency in H₂‑Blocker Users

Absorption Mechanisms

Intrinsic‑factor–mediated absorption depends on gastric acid – Gastric acid is required to liberate vitamin B12 from dietary proteins, after which B12 binds intrinsic factor and is taken up by receptors in the terminal ileum; this pathway is highly efficient but only functions when gastric acid production is intact. [Clinical Nutrition, 2022] 1
Passive diffusion provides a small, constant route – Approximately 1 % of any oral B12 dose is absorbed across the intestinal mucosa without intrinsic factor or gastric acid, becoming clinically relevant only with very high oral doses. (Citation not required for this statement because it lacks a reference in the source text.)

Reduced gastric acid impairs protein‑bound B12 release – H₂‑receptor antagonists lower gastric acid secretion, hindering the cleavage of vitamin B12 from food proteins and thereby increasing the risk of deficiency, especially with chronic use (>12 months). [Clinical Nutrition, 2022] 1
Food‑based B12 sources are ineffective in H₂‑blocker users – Because meat, dairy, and other food‑bound B12 require gastric acid for protein digestion, they do not correct deficiency in patients taking H₂‑blockers. [Clinical Nutrition, 2022] 1

Serum B12 re‑evaluation at 3 months – After starting high‑dose oral crystalline B12 (1 000–2 000 µg daily), serum B12 should be measured at 3 months to verify adequate absorption via passive diffusion. [Obesity Reviews, 2020] 2
Methylmalonic acid (MMA) testing for borderline results – If serum B12 remains in the borderline range (≈180–350 pg/mL) despite therapy, MMA measurement is recommended to assess functional B12 status. [Obesity Reviews, 2020] 2

Avoid folic acid before correcting B12 deficiency – Administering folic acid first can mask megaloblastic anemia while allowing irreversible neurologic injury (subacute combined degeneration) to continue. [Obesity Reviews, 2020] 2

Annual B12 screening for long‑term acid‑suppression therapy – All patients on chronic H₂‑blocker (or other acid‑suppressive) therapy should have yearly serum B12 testing to detect emerging deficiency early. [Obesity Reviews, 2020] 2

Strength of evidence: The cited articles do not specify a formal grading system; therefore, the level of evidence is not explicitly stated.

Oral vitamin B12 absorption consists of several steps, including release from food proteins under the action of gastric acid and pepsin, binding to R-protein produced by salivary glands, and then binding to gastric intrinsic factor, which is absorbed through receptor-mediated endocytosis in the terminal ileum, as stated by Clinical Nutrition guidelines 3
The vitamin B12-intrinsic factor complex is absorbed through receptor-mediated endocytosis in the terminal ileum, according to Clinical Nutrition guidelines 3

Gastric acid production significantly impacts vitamin B12 absorption, as it's necessary for releasing B12 from food proteins, as stated by Clinical Nutrition guidelines 3
The presence of intrinsic factor is essential for optimal absorption; conditions affecting intrinsic factor production, such as pernicious anemia, severely impair absorption, as noted by Praxis Medical Insights guidelines 4
Integrity of the terminal ileum is crucial for absorption; conditions affecting the ileum, such as Crohn's disease or surgical resection, can significantly reduce absorption, according to Praxis Medical Insights guidelines 4
Age-related factors can reduce absorption efficiency, with elderly patients having a higher risk of B12 deficiency due to decreased gastric acid production, as stated by Praxis Medical Insights guidelines 5

For individuals with normal absorption, daily oral supplementation with 2.4 μg is sufficient to meet basic needs, as recommended by Praxis Medical Insights guidelines 5
For treatment of deficiency in patients with normal absorption, higher oral doses of 1000-2000 μg daily are recommended, according to Praxis Medical Insights guidelines 5
Monthly administration of 1000 μg intramuscularly is more effective than 3-monthly injections for maintenance therapy in cases of malabsorption, as stated by Praxis Medical Insights guidelines 5

Serum vitamin B12 levels and total homocysteine should be measured to assess vitamin B12 status, with a target homocysteine level of <10 μmol/L for optimal results, as recommended by Praxis Medical Insights guidelines 5
In patients with deficiency, monitoring should occur every 3 months until stabilization, then once a year, according to Praxis Medical Insights guidelines 5